ArticleEvidence-based complementary and alternative medicine : eCAM2022

A Phase II, Randomized, Double-Blind, Double-Dummy, Active-Controlled Clinical Trial to Investigate the Efficacy and Safety of NW Low-Glu® in Patients Newly Diagnosed with Type 2 Diabetes Mellitus.

Samir Assaad-Khalil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.